MCID: UPP004
MIFTS: 46

Upper Respiratory Tract Disease malady

Categories: Respiratory diseases

Aliases & Classifications for Upper Respiratory Tract Disease

Aliases & Descriptions for Upper Respiratory Tract Disease:

Name: Upper Respiratory Tract Disease 12 14

Classifications:



External Ids:

Disease Ontology 12 DOID:974
ICD9CM 35 478.1 478.19
SNOMED-CT 64 195823002 266346007
ICD10 33 J39.8
UMLS 69 C0029581

Summaries for Upper Respiratory Tract Disease

Disease Ontology : 12 A respiratory system disease which involves the upper respiratory tract.

MalaCards based summary : Upper Respiratory Tract Disease is related to tuberculosis and pharyngitis. An important gene associated with Upper Respiratory Tract Disease is RNASE3 (Ribonuclease A Family Member 3), and among its related pathways/superpathways are Innate Immune System and Cytokine Signaling in Immune system. The drugs Nitric Oxide and Dexamethasone have been mentioned in the context of this disorder. Affiliated tissues include testes and brain, and related phenotypes are hematopoietic system and homeostasis/metabolism

Related Diseases for Upper Respiratory Tract Disease

Diseases related to Upper Respiratory Tract Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 218)
id Related Disease Score Top Affiliating Genes
1 tuberculosis 29.9 IL10 IL4 TNF
2 pharyngitis 10.8
3 scarlet fever 10.8
4 epiglottitis 10.8
5 adenoiditis 10.8
6 laryngotracheitis 10.8
7 uvulitis 10.8
8 adenoid hypertrophy 10.8
9 tonsillitis 10.8
10 common cold 10.8
11 acute laryngopharyngitis 10.8
12 marasmus 10.4 IL4 IL5 RNASE3
13 lens-induced iridocyclitis 10.4 IL4 IL5 RNASE3
14 renal hypertension 10.4 IL13 IL5 RNASE3
15 multiple epiphyseal dysplasia due to collagen 9 anomaly 10.4 IL4 IL5 RNASE3
16 dahlberg borer newcomer syndrome 10.4 IL13 IL5
17 anterior dislocation of lens 10.4 CCL11 IL4 RNASE3
18 latent syphilis 10.4 CCL11 IL5 RNASE3
19 necrotizing gastritis 10.4 CCL11 IL5 RNASE3
20 bone peripheral neuroepithelioma 10.4 IL13 IL4 IL5
21 lactose intolerance 10.4 IL13 IL4 IL5
22 askin's tumor 10.4 IL13 IL4 IL5
23 alkhurma hemorrhagic fever 10.4 CD79A IL4 RHNO1
24 duodenal somatostatinoma 10.4 IL13 IL4 IL5
25 cutaneous ganglioneuroma 10.4 CD79A IL4 RHNO1
26 infectious anterior uveitis 10.4 CXCL8 IL5 RNASE3
27 isthmus cancer 10.3 CCL11 CD79A IL4
28 breast intracanalicular fibroadenoma 10.3 CXCL8 IL4 IL5
29 psychotic disorder 10.3 CCL11 CXCL8 IL4
30 coenurosis 10.3 CD79A IL4 IL5
31 mesangial proliferative glomerulonephritis 10.3 CD79A CXCL8
32 aortic atherosclerosis 10.3 IL13 IL5 TNF
33 retinal vascular disease 10.3 CCL11 CXCL8 IL4
34 wilkes stevenson syndrome 10.3 CXCL8 IL5 RNASE3
35 urethral intrinsic sphincter deficiency 10.3 IL4 IL5 TNF
36 ovarian mucinous neoplasm 10.3 IL13 IL5 TSLP
37 spastic paraplegia 3a, autosomal dominant 10.3 IL13 IL4 IL5 RNASE3
38 lymphangiectasia, intestinal 10.3 CD79A IL4 RNASE3
39 luminal breast carcinoma 10.3 IL13 IL4 IL5 RNASE3
40 acute gonococcal prostatitis 10.3 IL13 IL4 IL5 RNASE3
41 barbiturate abuse 10.3 CCL11 CD79A IL4
42 pyridoxal 5'-phosphate-dependent epilepsy 10.3 IL10 TNF
43 clostridium difficile colitis 10.3 CD79A IL4 TNF
44 central nervous system origin vertigo 10.3 CD79A IL4 MS4A2 RNASE3
45 thelaziasis 10.3 CCL11 IL13 IL4 IL5
46 childhood malignant mesenchymoma 10.3 CCL11 IL13 IL5 RNASE3
47 mikulicz disease 10.3 CD79A IL4 TNF
48 lymphoblastic leukemia 10.3 CCL11 IL13 IL4 IL5
49 diabetic angiopathy 10.3 CD79A IL10 IL4
50 metal allergy 10.3 CD79A IL13 IL5 RNASE3

Graphical network of the top 20 diseases related to Upper Respiratory Tract Disease:



Diseases related to Upper Respiratory Tract Disease

Symptoms & Phenotypes for Upper Respiratory Tract Disease

MGI Mouse Phenotypes related to Upper Respiratory Tract Disease:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10.1 CCL11 CD79A CHD7 HRH1 IL10 IL13
2 homeostasis/metabolism MP:0005376 9.97 CD79A CHD7 HRH1 IL10 IL13 IL33
3 digestive/alimentary MP:0005381 9.92 IL33 IL4 IL5 TNF TSLP CHD7
4 immune system MP:0005387 9.83 TSLP CCL11 CD79A CHD7 CYSLTR1 HRH1
5 respiratory system MP:0005388 9.36 CCL11 CHD7 CYSLTR1 IL10 IL13 IL33

Drugs & Therapeutics for Upper Respiratory Tract Disease

Drugs for Upper Respiratory Tract Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 863)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Nitric Oxide Approved Phase 4,Phase 2,Phase 1 10102-43-9 145068
2
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3 50-02-2 5743
3
Zinc Approved Phase 4,Phase 3,Phase 2 7440-66-6 32051 23994
4
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2 50-78-2 2244
5
Cisplatin Approved Phase 4,Phase 3,Phase 2,Phase 1 15663-27-1 84093 441203 2767
6
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 51-43-4 5816
7
Midazolam Approved, Illicit Phase 4,Phase 3,Phase 2 59467-70-8 4192
8
Montelukast Approved Phase 4,Phase 3 158966-92-8 5281040
9
Penicillin G Approved, Vet_approved Phase 4 61-33-6 5904
10
Ciprofloxacin Approved, Investigational Phase 4 85721-33-1 2764
11
Acetaminophen Approved Phase 4,Phase 3,Phase 2 103-90-2 1983
12
Atropine Approved, Vet_approved Phase 4 5908-99-6, 51-55-8 174174
13
Cilostazol Approved Phase 4 73963-72-1 2754
14
Ribavirin Approved Phase 4,Phase 3,Phase 2 36791-04-5 37542
15
Histamine Approved, Investigational Phase 4,Phase 3,Phase 1 75614-87-8, 51-45-6 774
16
Ephedrine Approved Phase 4,Phase 3,Phase 2,Phase 1 299-42-3 9294
17
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 1 50-24-8 5755
18
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
19
Budesonide Approved Phase 4,Phase 3,Phase 2 51333-22-3 63006 5281004
20
Lidocaine Approved, Vet_approved Phase 4,Phase 3 137-58-6 3676
21
Azithromycin Approved Phase 4,Phase 3,Phase 2 83905-01-5 55185 53477736 447043
22
Acetazolamide Approved, Vet_approved Phase 4,Phase 1 59-66-5 1986
23
Ketamine Approved, Vet_approved Phase 4,Phase 3 6740-88-1 3821
24
Clarithromycin Approved Phase 4,Phase 1 81103-11-9 84029
25
Amoxicillin Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 26787-78-0 33613 2171
26
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 2 2078-54-8 4943
27
Moxifloxacin Approved, Investigational Phase 4,Phase 1,Phase 2 354812-41-2, 151096-09-2 152946
28
Lansoprazole Approved, Investigational Phase 4,Phase 1 103577-45-3 3883
29
Codeine Approved, Illicit Phase 4,Phase 2 76-57-3 5284371
30
Imipenem Approved Phase 4 74431-23-5 104838
31
Tadalafil Approved, Investigational Phase 4 171596-29-5 110635
32
Omalizumab Approved, Investigational Phase 4,Phase 2,Phase 3 242138-07-4
33
Benzocaine Approved Phase 4,Phase 3,Phase 1 1994-09-7, 94-09-7 2337
34
Pseudoephedrine Approved Phase 4,Phase 3,Phase 2,Phase 1 90-82-4 7028
35
Menthol Approved Phase 4,Phase 3,Phase 1,Phase 2 2216-51-5 16666
36
Ropivacaine Approved Phase 4,Phase 1 84057-95-4 71273 175805
37
Tazobactam Approved Phase 4 89786-04-9 123630
38
Piperacillin Approved Phase 4 66258-76-2 43672
39
Cefuroxime Approved Phase 4 55268-75-2 5361202 5479529
40
Dextromethorphan Approved Phase 4,Phase 3,Phase 1,Phase 2 125-71-3 5360696 5362449
41
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 1 83-43-2 6741
42
Pemetrexed Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 150399-23-8, 137281-23-3 446556 60843
43
Acetylcysteine Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 616-91-1 12035
44
Nitrous oxide Approved, Vet_approved Phase 4,Phase 2 10024-97-2 948
45
Guaifenesin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 93-14-1 3516
46 Beractant Approved Phase 4 108778-82-1
47 Poractant alfa Approved Phase 4 129069-19-8
48
Ethanol Approved Phase 4,Phase 3 64-17-5 702
49
Norepinephrine Approved Phase 4,Phase 2 51-41-2 439260
50
Dopamine Approved Phase 4,Phase 2,Phase 1 51-61-6, 62-31-7 681

Interventional clinical trials:

(show top 50) (show all 1573)
id Name Status NCT ID Phase
1 AeriSeal System in Patients With Advanced Upper Lobe Predominant Emphysema and Collateral Ventilation Unknown status NCT01460108 Phase 4
2 Procalcitonin as a Marker of Antibiotic Therapy in Patients With Lower Respiratory Tract Infections Unknown status NCT02171338 Phase 4
3 Determining the Minimal Effective Volume (MEAV95) for Interscalene Brachial Plexus Block for Surgical Anesthesia Unknown status NCT01703130 Phase 4
4 Simple Verbal Intervention for Adequately Collecting Sputum Unknown status NCT01135043 Phase 4
5 Effects of Exercise Training on Systemic Inflammation an Muscle Repair According to the Obstructive Chronic Pulmonary Disease (COPD) Phenotype Unknown status NCT01431625 Phase 4
6 Comparing Treatment Efficacy With HD/MD Flu Plus Sal in Chronic Obstructive Pulmonary Disease (COPD) Patients Unknown status NCT01131806 Phase 4
7 Inflammatory Response to Anti Inflammatory Therapy in Children With Sleep Disordered Breathing Unknown status NCT00299910 Phase 4
8 Brain Oxygenation and Function of Preterm Newborns During Administration of Two Different Surfactant Preparations Unknown status NCT01941524 Phase 4
9 Validation of Functional Imaging as Predictive Tool for Outcome of Mandibular Replacement Appliance Therapy in Obstructive Sleep Apnea Hypopnea Syndrome Patients Unknown status NCT01524510 Phase 4
10 A Prospective Randomised Controlled Trial of Management of Recurrent Nosebleeds in Children Unknown status NCT00390663 Phase 4
11 Influenza Vaccination in Patients With Scleroderma Unknown status NCT01002508 Phase 4
12 Vaccination Against Pertussis, Tetanus and Diphtheria in Patients Suffering From Rheumatoid Arthritis Unknown status NCT01301703 Phase 4
13 Safety and Efficacy of Intradermal Trivalent Influenza Vaccination in Institutionalized Older Adults Unknown status NCT01967368 Phase 4
14 Surfactant Administration During Spontaneous Breathing Unknown status NCT01329432 Phase 4
15 Pharmacodynamics Study of Imipenem in Patients With Ventilator Associated Pneumonia Unknown status NCT01379157 Phase 4
16 Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil Hypertrophy Unknown status NCT01328652 Phase 4
17 THE USE OF N-ACETYLCYSTEINE ATTENUATING CISPLATIN-INDUCED TOXICITIES BY OXIDATIVE STRESS Unknown status NCT02241876 Phase 4
18 Saline Injection - Assisted Anesthesia in Eyelid Surgery Unknown status NCT01239498 Phase 4
19 The Effect of "Eye Drop Guide" on the Success Rate of Eye Drops Self-instillation in Glaucoma Patients Unknown status NCT01704248 Phase 4
20 Trial of Chinese Herbal Medicine in the Treatment of Upper Respiratory Tract Infections (URTIs) Completed NCT00887172 Phase 4
21 DIAMANTE - Diseases Infectious Analysis Microflora Antibiotic Effect Completed NCT00424905 Phase 4
22 Placebo and Active Controlled Study to Compare the Antipyretic Efficacy of Aspirin® in Patients With Acute Febrile Upper Respiratory Tract Infections Suspected to be of Viral Origin Completed NCT01464944 Phase 4
23 The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Influenza (Acute Upper Respiratory Infection) Completed NCT02622659 Phase 4
24 Evaluate the Potential of Montelukast to Prevent Nasal Symptomatology During Colds Completed NCT00189475 Phase 4
25 Effect of Lactobacillus Reuteri in Cystic Fibrosis Completed NCT01737983 Phase 4
26 Remifentanil and Laryngeal Reflex Responses in Pediatric Patients With URI Completed NCT00611195 Phase 4
27 Compliance And Safety Study In Children With Upper And Lower Respiratory Tract Infections Completed NCT00939185 Phase 4
28 A Study to Evaluate the Efficacy of the Nasal Antiseptic, PrevinC, When Administered for the RiskReduction of Rhinitis in Subjects Who Work for Child Day Care Centers Completed NCT02225912 Phase 4
29 Intermittent Use of Aerosolized Ribavirin for Treatment of RSV Completed NCT00500578 Phase 4
30 Comparison of Efficacy and Tolerability of Two Cough Syrups in Cough Due to Cold in Children. Completed NCT01968434 Phase 4
31 PulmonarOM (Bacterial Lysates) in Respiratory Tract Infections Completed NCT00599417 Phase 4
32 Prevention of Respiratory Infections and MAnagement Among Children (PRIMAKid) Completed NCT00161122 Phase 4
33 Effectiveness of a Handwashing Programme in the Prevention of School Absenteeism Due to Respiratory Infections Completed NCT01728090 Phase 4
34 Vitamin A and Zinc: Prevention of Pneumonia (VAZPOP) Study Completed NCT00228254 Phase 4
35 Assess Particle Deposition and Acute Effects of Symbicort® Forte Turbohaler®) in COPD Patients. Completed NCT01329276 Phase 4
36 Clinical Trial of Fluticasone Versus Placebo at the Onset of a Cold for Children With Asthma Completed NCT00238927 Phase 4
37 SCOPE-Study: Salzburg Chronic Obstructive Pulmonary Disease- Exercise and Oxygen Study Completed NCT01150383 Phase 4
38 Conventional Versus Ultrasound-guided Transbronchial Needle Aspiration for the Diagnosis of Hilar/Mediastinal Lymphadenopathies Completed NCT01658280 Phase 4
39 Study of the Effect of Probiotics on Respiratory Morbidity After Influenza Vaccination of Elderly in Nursing Homes Completed NCT00849277 Phase 4
40 Immunogenicity, Safety and Tolerability of a Trivalent Subunit Inactivated Vaccine in Healthy Subjects 50 Years and Above Completed NCT01867021 Phase 4
41 Symptomatic Treatment of Common Cold Symptoms Completed NCT01033526 Phase 4
42 Inspire® Upper Airway Stimulation (UAS) System German Post-Market Study Completed NCT02293746 Phase 4
43 Effects of a Common Cold Treatment on Cognitive Function Completed NCT01466348 Phase 4
44 Efficacy of Nebulised Beclometasone in Viral Wheezing Prophylaxis Completed NCT01265342 Phase 4
45 Lung Function and Patient Preference With QVA149 vs. Tiotropium in COPD Patients Completed NCT02125734 Phase 4
46 Nebulized 5% Hypertonic Saline for the Treatment of Bronchiolitis Completed NCT01016249 Phase 4
47 Serotonin and the Upper Airway in Obstructive Sleep Apnea Completed NCT00100464 Phase 4
48 Beta Blocker Therapy in Moderate to Severe COPD Completed NCT01656005 Phase 4
49 Clevidipine for Vasoreactivity Evaluation of the Pulmonary Arterial Bed Completed NCT01121458 Phase 4
50 Dexmedetomidine and Propofol in Children With History of Obstructive Sleep Apnea Completed NCT01344759 Phase 4

Search NIH Clinical Center for Upper Respiratory Tract Disease

Genetic Tests for Upper Respiratory Tract Disease

Anatomical Context for Upper Respiratory Tract Disease

MalaCards organs/tissues related to Upper Respiratory Tract Disease:

39
Testes, Brain

Publications for Upper Respiratory Tract Disease

Articles related to Upper Respiratory Tract Disease:

(show top 50) (show all 53)
id Title Authors Year
1
Prevalence of feline herpesvirus-1, feline calicivirus, Chlamydophila felis and Mycoplasma felis DNA and associated risk factors in cats in Spain with upper respiratory tract disease, conjunctivitis and/or gingivostomatitis. ( 26919892 )
2016
2
Exposure of rhesus monkeys to cowpox virus Brighton Red by large-particle aerosol droplets results in an upper respiratory tract disease. ( 27166137 )
2016
3
Detection of feline upper respiratory tract disease pathogens using a commercially available real-time PCR test. ( 26324635 )
2015
4
Sampling sites for detection of feline herpesvirus-1, feline calicivirus and Chlamydia felis in cats with feline upper respiratory tract disease. ( 25660223 )
2015
5
Mycoplasmosis and upper respiratory tract disease of tortoises: a review and update. ( 24951264 )
2014
6
An association between Helicobacter pylori and upper respiratory tract disease: fact or fiction? ( 24587622 )
2014
7
Surveillance for upper respiratory tract disease and Mycoplasma in free-ranging gopher tortoises (Gopherus polyphemus) in Georgia, USA. ( 25098305 )
2014
8
Impacts of upper respiratory tract disease on olfactory behavior of the Mojave desert tortoise. ( 24506425 )
2014
9
Effects of mycoplasmal upper-respiratory-tract disease on movement and thermoregulatory behavior of gopher tortoises (Gopherus polyphemus) in Georgia, USA. ( 25121399 )
2014
10
Surveillance of upper respiratory tract disease in owned cats in Australia, 2009-2012. ( 23910025 )
2013
11
Mycoplasmal upper respiratory tract disease across the range of the threatened Mojave Desert tortoise: associations with thermal regime and natural antibodies. ( 23579813 )
2013
12
Comparison of the efficacy of amoxicillin-clavulanic acid, cefovecin, and doxycycline in the treatment of upper respiratory tract disease in cats housed in an animal shelter. ( 22765368 )
2012
13
Upper respiratory tract disease in captive orangutans (Pongo sp.): prevalence in 20 European zoos and predisposing factors. ( 21770970 )
2011
14
Infectious causes for feline upper respiratory tract disease--a case-control study. ( 20851008 )
2010
15
Flow cytometric method for quantifying viable Mycoplasma agassizii, an agent of upper respiratory tract disease in the desert tortoise (Gopherus agassizii). ( 20132436 )
2010
16
Effects of mycoplasmal upper respiratory tract disease on morbidity and mortality of gopher tortoises in northern and central Florida. ( 20688675 )
2010
17
Detection of bacterial and viral organisms from the conjunctiva of cats with conjunctivitis and upper respiratory tract disease. ( 20817584 )
2010
18
Upper respiratory tract disease, force of infection, and effects on survival of gopher tortoises. ( 19425439 )
2009
19
Descriptive epidemiology of feline upper respiratory tract disease in an animal shelter. ( 19782625 )
2009
20
Prevalence of selected infectious organisms and comparison of two anatomic sampling sites in shelter cats with upper respiratory tract disease. ( 18539065 )
2008
21
Efficacy of pradofloxacin in cats with feline upper respiratory tract disease due to Chlamydophila felis or Mycoplasma infections. ( 18289288 )
2008
22
Risk factors for time to diagnosis of feline upper respiratory tract disease in UK animal adoption shelters. ( 18639946 )
2008
23
Nasal levels of nitric oxide as an outcome variable in allergic upper respiratory tract disease: Influence of atopy and hayfever on nNO. ( 17063731 )
2006
24
An investigation into the role of Chlamydophila spp. in bovine upper respiratory tract disease. ( 16624729 )
2006
25
Factors associated with upper respiratory tract disease caused by feline herpesvirus, feline calicivirus, Chlamydophila felis and Bordetella bronchiseptica in cats: experience from 218 European catteries. ( 15908495 )
2005
26
Correlation of rhinoscopic signs of inflammation with histologic findings in nasal biopsy specimens of cats with or without upper respiratory tract disease. ( 15328715 )
2004
27
Mycoplasma testudineum sp. nov., from a desert tortoise (Gopherus agassizii) with upper respiratory tract disease. ( 15388705 )
2004
28
Occurrence of infectious upper respiratory tract disease and response to vaccination in horses on six sentinel premises in northern Colorado. ( 12553466 )
2003
29
Upper respiratory tract disease in tortoises. ( 14509583 )
2003
30
An etiological investigation of domestic cats with conjunctivitis and upper respiratory tract disease in Japan. ( 11999440 )
2002
31
Pathology of upper respiratory tract disease of gopher tortoises in Florida. ( 10813609 )
2000
32
Feline upper respiratory tract disease. ( 10907225 )
2000
33
A study of feline upper respiratory tract disease with reference to prevalence and risk factors for infection with feline calicivirus and feline herpesvirus. ( 11716607 )
2000
34
Seroepidemiology of upper respiratory tract disease in the desert tortoise in the western Mojave Desert of California. ( 10574531 )
1999
35
Prevalence of feline Chlamydia psittaci and feline herpesvirus 1 in cats with upper respiratory tract disease. ( 10357102 )
1999
36
Upper respiratory tract disease in the gopher tortoise is caused by Mycoplasma agassizii. ( 10364595 )
1999
37
Relationship between clinical signs of upper respiratory tract disease and antibodies to Mycoplasma agassizii in desert tortoises from Nevada. ( 9131556 )
1997
38
Upper respiratory tract disease and mycoplasmosis in desert tortoises from Nevada. ( 9391959 )
1997
39
Comparison of Chlamydia psittaci from cats with upper respiratory tract disease by polymerase chain reaction analysis of the ompA gene. ( 9106964 )
1997
40
Molecular characterization of Pasteurella testudinis isolated from desert tortoises (Gopherus agassizii) with and without upper respiratory tract disease. ( 7563420 )
1995
41
Mycoplasma agassizii causes upper respiratory tract disease in the desert tortoise. ( 7927724 )
1994
42
Detection of antibodies to a pathogenic mycoplasma in desert tortoises (Gopherus agassizii) with upper respiratory tract disease. ( 8314986 )
1993
43
Chronic upper respiratory tract disease of free-ranging desert tortoises (Xerobates agassizii). ( 2067052 )
1991
44
Bacterial adherence and upper respiratory tract disease: a correlation between S. pyogenes attachment and recurrent throat infections. ( 3066104 )
1988
45
Epidemiology of equine upper respiratory tract disease on standardbred racetracks. ( 218705 )
1979
46
Intranasal vaccination against upper respiratory tract disease (U.R.D.) in the cat--II. Results of field studies under enzootic conditions in the Netherlands with a combined vaccine containing live attenuated calici- and herpesvirus. ( 757151 )
1978
47
Intranasal vaccination against upper respiratory tract disease (U.R.D.) in the cat--I. Virological and serological observations in cats suffering from U.R.D. ( 757150 )
1978
48
Office diagnosis of streptococcal upper respiratory tract disease. ( 1091982 )
1975
49
Viral isolation rates during summer from children with acute upper respiratory tract disease and healthy children. ( 4358333 )
1974
50
Bacterial and viral throat flora. Comparison of findings in children with acute upper respiratory tract disease and in healthy controls during winter. ( 4396432 )
1971

Variations for Upper Respiratory Tract Disease

Expression for Upper Respiratory Tract Disease

Search GEO for disease gene expression data for Upper Respiratory Tract Disease.

Pathways for Upper Respiratory Tract Disease

Pathways related to Upper Respiratory Tract Disease according to GeneCards Suite gene sharing:

(show all 31)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
14 CCL11 CD79A CXCL8 IL10 IL13 IL33
2
Show member pathways
13.31 CCL11 CXCL8 IL10 IL13 IL33 IL4
3
Show member pathways
13.25 CCL11 CXCL8 IL10 IL13 IL4 IL5
4
Show member pathways
12.8 CCL11 CXCL8 IL10 IL13 IL4 IL5
5
Show member pathways
12.74 CXCL8 IL13 IL33 IL4 TNF
6
Show member pathways
12.59 CD79A IL10 IL4 MS4A2 TNF
7
Show member pathways
12.57 CD79A IL13 IL4 IL5 MS4A2 TNF
8
Show member pathways
12.54 IL10 IL13 IL4 IL5 TNF
9
Show member pathways
12.36 IL10 IL4 IL5 TNF
10
Show member pathways
12.31 CCL11 CXCL8 IL13 IL4 IL5 MUC5B
11
Show member pathways
12.2 IL10 IL13 IL4 IL5 TSLP
12
Show member pathways
12.2 CXCL8 IL10 IL13 IL4 IL5 TNF
13
Show member pathways
12.14 CCL11 CXCL8 IL4 TNF
14 12.13 CXCL8 IL10 IL13 TNF
15 12.02 CD79A IL10 IL4 IL5 PTGDR2 TNF
16 11.99 CCL11 CXCL8 IL10 IL13 IL4 TNF
17 11.81 CXCL8 IL13 IL4 IL5
18
Show member pathways
11.77 CXCL8 IL4 IL5 TNF
19 11.72 IL10 IL4 IL5 TNF
20 11.7 CXCL8 IL10 TNF
21 11.64 CCL11 IL10 IL4 IL5
22 11.58 CXCL8 IL10 IL13 IL4 TNF
23 11.48 CXCL8 IL10 TNF
24 11.41 CCL11 IL10 IL13 IL33 IL4 IL5
25 11.3 CCL11 CXCL8 IL13 IL4 IL5 MUC5B
26 11.24 IL10 IL13 IL4 IL5
27 11.2 IL10 IL13 IL4 IL5 TNF
28 11.14 CCL11 CXCL8 IL10 IL13 IL4 IL5
29 11.14 IL13 IL33 IL4 IL5 TNF TSLP
30 11.13 IL10 IL13 IL33 IL4 IL5 PTGDR2
31 10.9 IL13 IL4 IL5

GO Terms for Upper Respiratory Tract Disease

Cellular components related to Upper Respiratory Tract Disease according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.7 CCL11 CXCL8 IL10 IL13 IL33 IL4
2 external side of plasma membrane GO:0009897 9.55 CD79A IL13 IL4 MS4A2 TNF
3 extracellular space GO:0005615 9.36 CCL11 CXCL8 IL10 IL13 IL33 IL4

Biological processes related to Upper Respiratory Tract Disease according to GeneCards Suite gene sharing:

(show all 29)
id Name GO ID Score Top Affiliating Genes
1 defense response to bacterium GO:0042742 9.9 IL10 MUC5B RNASE3 TNF
2 B cell differentiation GO:0030183 9.77 CD79A IL10 IL4
3 chemotaxis GO:0006935 9.72 CCL11 CXCL8 CYSLTR1 IL4 PTGDR2
4 positive regulation of sequence-specific DNA binding transcription factor activity GO:0051091 9.67 IL10 IL4 IL5 TNF
5 positive regulation of B cell proliferation GO:0030890 9.65 IL13 IL4 IL5
6 microglial cell activation GO:0001774 9.64 IL13 IL4
7 negative regulation of nitric oxide biosynthetic process GO:0045019 9.64 IL10 IL4
8 response to molecule of bacterial origin GO:0002237 9.63 CXCL8 IL10
9 positive regulation of heterotypic cell-cell adhesion GO:0034116 9.63 IL10 TNF
10 positive regulation of podosome assembly GO:0071803 9.62 IL5 TNF
11 positive regulation of immunoglobulin secretion GO:0051024 9.62 IL33 IL5
12 positive regulation of chemokine biosynthetic process GO:0045080 9.61 IL4 TNF
13 positive regulation of mast cell degranulation GO:0043306 9.61 IL13 IL4
14 eosinophil chemotaxis GO:0048245 9.58 CCL11 HRH1
15 endothelial cell apoptotic process GO:0072577 9.58 IL10 TNF
16 negative regulation of endothelial cell apoptotic process GO:2000352 9.58 IL10 IL13 I